JAGSNPHARM Jagsonpal Pharmaceuticals Ltd Other Situations Announcement 2025 - Clarification Submitted JAGSONPAL PHARMACEUTICALS LTD. clarified a delay in disclosing a material event regarding their Tolnaftate product due to it falling below the materiality threshold as per SEBI regulations, in response to a SEBI circular dated November 11, 2024..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Jagsonpal Pharmaceuticals Ltd